Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference
October 23, 2024
Glen Allen, VA, October 23, 2024 – PRISM MediaWire – Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on